Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

NCT: NCT02520986 · COMPLETED

NCT IDNCT02520986
StatusCOMPLETED
Start Date2016-10-25
Completion2026-01-19
SponsorRuhr University of Bochum (OTHER)
First posted
Last updated

Brief Summary

In a randomized clinical trial of 114 women undergoing Treatment for condyloma acuminata, two surgical methods, the carbon dioxide laser Ablation and the excision by electrocoagulation, will be compared. The primary outcome of the study is the cosmetic result judged by the Patient 6 weeks after Treatment using a 11-step numerical rating scale (NRS), secondary outcomes are intervention time, operative complications, subjects and users satisfaction, postoperative pain and recurrence of genital warts.

Frequently Asked Questions

What is Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma?

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma is a clinical trial registered under NCT02520986. Current status: COMPLETED.

What is the status of NCT02520986?

The current status of NCT02520986 (Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma) is: COMPLETED.

When did Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma start?

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma started on 2016-10-25.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.